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Abstract: Pancreatic secretion can be influenced by cholecystokinin (CCK) either directly via actions on acinar cells or
indirectly via actions on nerves. The presence and functional roles of CCK receptors on human pancreatic acinar cells
remains unclear. In the current study human pancreatic acini were isolated and then treated with CCK-8, gastrin and/or
carbachol. Functional parameters were measured including intracellular [Ca2π] and amylase secretion. It was observed
that human acini did not respond to CCK agonists but did respond to carbachol with robust increases in functional
parameters. Adenoviral-mediated gene transfer of CCK1 or CCK2 receptors to the human cells resulted in cell responses
to CCK agonists. In order to determine the reason for the lack of responsiveness of the human acini, expression of
receptor mRNAs was determined using quantitative RT-PCR and localized by in situ hybridization. mRNA levels for
CCK1 receptors were ∂30 times lower than those of CCK2 receptors, which were ∂10 times lower than those of m3 Ach
receptors as measured by quantitative PCR. Neither CCK1 nor CCK2 receptors were localized in adult human pancreas
by in situ hybridization. These results indicate that human pancreatic acinar cells do not respond directly to CCK receptor
activation and this is likely due to an insufficient level of receptor expression.
A major physiological function of cholecystokinin (CCK)
in human physiology is the stimulation of pancreatic en-
zyme secretion, a phenomenon that has been known for
nearly 60 years (Harper & Raper 1943). However, the mech-
anisms involved in this response in man remain contro-
versial (Niederau et al. 1994; Owyang 1996; Adler 1997).
Confusion has arisen due to basic differences between the
mechanisms that exist in commonly utilized rodent animal
models and those that exist in man. Administration of CCK
leads to a rapid increases in pancreatic secretion in both
rodents and man (Wank 1995). In rodents it appears that
two mechanisms are likely involved, one indirect and one
direct. The indirect mechanism involves the binding of CCK
to CCK1 receptor expressed in afferent neurones that in-
fluence pancreatic secretion by way of a vagal-vagal loop
with the final mediator being acetylcholine acting at m3
muscarinic cholinergic receptors (m3 AchR) (Owyang 1996;
Adler 1997). This mechanism has also been reported to
exist in man (Owyang 1996). The direct mechanism involves
the binding of CCK to CCK1 receptors that are expressed
in pancreatic acinar cells leading to an increase in intracellu-
lar Ca2π and secretion of digestive enzymes that can be
observed in vitro (Jensen et al. 1989). It is unclear whether
this direct mechanism exists in man as the presence and
identity of CCK receptors on human pancreatic acinar cells
remains controversial despite several studies (Miller 1996).
Our laboratory has evaluated the presence and identity of
CCK receptors in pancreatic acinar prepared from normal
human pancreas with a focus on their functional roles (Ji et
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al. 2001). As reviewed here, these results show that human
pancreatic acinar cells do not respond significantly to CCK
or gastrin and suggest that this lack of responsiveness is
related to a low level of receptor expression. These data
therefore support the conclusion that the stimulatory effects
of CCK on pancreatic secretion in humans are mediated
exclusively through an indirect pathway.
Materials and Methods
Materials. Amylase 3 reagent (4,6-Ethylidene (G7)-p-nitrophenyl
(G1)-alpha-D-Maltoheptaoside) was obtained from Sigma (St.
Louis, MO, USA). Fura 2-AM was purchased from Molecular
Probes (Eugene, OR, USA). Collagenase (CLSPA grade) was pur-
chased from Worthington Biochemicals (Freehold, NJ, USA). Sul-
fated CCK-8 was obtained from Bachem Bioscience Inc. (Torrance,
CA, USA). I-Cycler real-time PCR detection system were obtained
from Bio-Rad (Hercules, CA, USA). Trizol reagent was from Gibco
BRL (Grand Island, NY, USA). The RNeasyA kit and DNase were
products of Qiagen (Valencia, CA, USA). SYBR green IA nucleic
acid stain was from FMC Bioproducts (Rockkland, ME, USA).
ECLA chemiluminescent reagent and HybondA Nylon membranes
were from Amersham Pharmacia Biotech (Piscataway, NJ, USA).
Primers were synthesized at the University of Michigan DNA core.
Recombinant adenoviruses encoding CCK receptors. The recombin-
ant adenovirus encoding the rat CCK1 receptor has been previously
described (Ji et al. 2000). The current study utilized a recombinant
adenovirus encoding the human CCK2 receptor produced by a
similar strategy.
Preparation of acini and infection with virus. Specimens of normal
human pancreas were obtained from 6 patients undergoing resec-
tion of pancreatic tumours at the University of Michigan Hospital,
or from 3 organ donors provided by the Michigan Transplantation
Society with no differences noted between acini prepared from these
two groups. All human subjects were adults and males and females
were treated equally. All experiments were conducted with per-
mission of the University of Michigan Internal Review Board for
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use of Human Materials. Acini were prepared by a modification of
the methods previously described for the preparation of rodent
acini (Ji et al. 2000 & 2001). The acini were suspended in HEPES-
Ringer buffer (HR) containing 1% bovine serum albumin. The pH
was adjusted to 7.4 and equilibrated with 100% O2 before use. In
some experiments the acini were infected with virus encoding the
human CCK2 or rat CCK1 receptor essentially as previously de-
scribed (Ji et al. 2000).
Analysis of amylase secretion. Amylase secretion in response to
CCK-8, gastrin or carbachol was measured as described previously
(Ji et al. 2000). Results were expressed as a percentage of initial
acinar amylase content released.
Analysis of intracellular Ca2πlevels. Analysis of intracellular Ca2π
concentration was conducted using ratio metric imaging of Fura-2-
loaded cells as described previously (Ji et al. 2000 & 2001).
RT-PCR. Standard RT-PCR was conducted using total RNA pre-
pared from human pancreatic acini and whole pancreas isolated
using TriZol reagent (Gibco, Grand Island, NY, USA). RNA was
purified by digestion for 15 min. with DNase and recovery of RNA
using an RNeasy kit (Qiagen, Valencia CA, USA). Reverse tran-
scription was conducted for 45 min. at 48æ from 70 ng purified
total RNA in a 25 ul volume of Access RT-PCR reaction mixture
(Promega, Madison, WI, USA) followed by 40 cycles of standard
PCR (30 sec. denaturation at 94æ, 1 min. annealing at 56æ and 1.5
min extension at 68æ). All PCR products were verified by sequenc-
ing. Quantitative RT-PCR was conducted by previously published
methods (Higuchi et al. 1993; Ji et al. 2001). SYBR green I was
used to monitor the PCR products on the I-Cycler thermal cycler
and IQ real-time PCR detection system (BioRad, Hercules, CA,
USA). Primers designed for the human CCK1 receptor (Genebank
accession L13605) were: forward 5ø TGC GGA CGG TCA CCA
ACA TCT T 3ø and reverse 5øGCA CAG GAA GAA GAG GAC
CAC GAT3ø. Those for the CCK2 receptor (Genebank accession
L08112) were: forward 5øGTG ACA GCG ACA GCC AAA GCA
G 3ø and reverse 5øCGA GGC GTA GCT CAG CAA GTG A 3ø.
Those for the m3 Ach receptor (Genebank accession NM–000740)
were: forward 5øATC GGT CTG GCT TGG GTC ATC TC 3ø and
reverse 5øAGC GGC CAT ACT TCC TCC TGT TG 3øs. Those
for insulin (Genebank accession XM–006400) were: forward 5øAAG
AGG CCA TCA AGC ACA TCA CTG 3ø and reverse 5øGGT
TCA AGG GCT TTA TTC CAT CTC 3ø. Standard curves were
prepared using known amounts of plasmids bearing full-length
cDNAs and were linear over 5 log units with correlation coefficients
of greater than 0.98. The estimate of cell numbers was based upon
the value of RNA per pancreatic acinar cell (65 pg) previously
measured in the rat (Swift et al. 1984).
In situ hybridization. In situ hybridization assays were performed
with slight modifications of previously described methods (Panos-
kaltsis-Mortari et al. 1995) as previously described (Ji et al. 2001).
Results
Human pancreatic acinar cells do not respond functionally to
cholecystokinin or gastrin.
To test whether activation of CCK receptors directly causes
human pancreatic acini to secrete digestive enzymes, we iso-
lated acini from portions of normal human pancreas surgic-
ally removed during pancreatic cancer resection or from or-
gan donors. Isolated acini appeared intact with obvious po-
larity and viability was indicated by exclusion of the vital
dye trypan blue (data not shown). These acini were then
treated with CCK, gastrin, or as a positive control, with the
acetylcholine analogue, carbachol. Treatment with neither
CCK-8 nor gastrin caused any increase in amylase secretion
even at supraphysiologic concentrations of 100 nM (fig. 1).
In contrast, the isolated acini responded to stimulation
with carbachol in a concentration-dependent manner with
maximal stimulation of 6.4∫0.3 % total amylase per 30
min., (nΩ3) with 1 mM carbachol.
This represented an increase of approximately 6 times of
the basal amylase secretion (1.1∫0.08 % total amylase per
30 min., nΩ3). That the acini had low levels of basal secre-
tion and responded to carbachol supported the conclusion
that the isolated acini were functionally intact. To distin-
guish between a lack of response due to insufficient CCK
receptors versus a lack of CCK receptor related signaling
molecules such as G-proteins, we next expressed human
CCK2 receptors in acini using adenoviral mediated gene
transfer as described previously (Ji et al. 2000). Infected
acini were incubated for 4 hr, as this amount of time was
previously shown to allow a level of expression of receptors
in acini isolated from receptor deficient mice that was
equivalent to that observed in the control mice (Ji et al.
2000). Acini infected with the receptor coding adenovirus
responded to CCK-8 with a concentration dependent re-
lease of amylase that was similar in magnitude to that
stimulated by carbachol (fig. 1). Infection with a control
adenovirus had no effect on the responsiveness of the acini
to CCK analogues (data not shown). These data suggested
that the isolated acini were healthy and the lack of response
of the isolated acini was not due to a lack of intracellular
signaling mechanisms.
Acinar cell secretion mediated by CCK is triggered by an
increase in intracellular Ca2π concentration. The ability of
secretagogues to increase intracellular Ca2π is highly sensi-
tive and more proximal to receptor activation than is secre-
Fig. 1. Human pancreatic acini secrete amylase in response to car-
bachol but not to CCK-8 or gastrin. Isolated human pancreatic
acini either uninfected, or infected for 4 hr with an adenovirus ex-
pressing the human CCK2 receptor, were incubated with increasing
concentrations of CCK-8, gastrin or carbachol at 37æ for 30 min.
The concentration of amylase released into the medium was meas-
ured using colorimetric reagent and was expressed as a percentage
of initial acinar amylase content. Data shown are means of three
separate experiments (reproduced from Ji et al. 2001 with per-
mission).
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Fig. 2. Human pancreatic acini increase their level of intracellular Ca2π in response to carbachol but not to CCK-8. Measurement of
emitted fluorescence allowing an estimation of intracellular Ca2πwere performed with fura2-loaded acini using an Attofluor digital imaging
system. At the times indicated CCK-8 (100 nM) or carbachol (1 mM) were introduced. A. Freshly prepared acini were treated with CCK-8
and then carbachol. B. Acini that were infected with the adenovirus bearing human CCK2 receptor for 4 hr were treated with CCK-8 (100
nM). C. Acini that were infected with the adenovirus bearing rat CCK1 receptor for 4 hr were treated with CCK-8 (100 nM). Data shown
are typical and were representatives of 4 separate experiments. (reproduced from Ji et al. 2001 with permission).
tion. Therefore, we tested whether or not human acinar cells
would respond to cholecystokinin analogues by an increase
in this parameter using fluorometric analysis of Ca2π levels
with the sensitive dye, Fura-2. Isolated human pancreatic
acinar cells did not respond to CCK-8 (fig. 2) or gastrin
(data not shown) even at concentrations of 100 nM. How-
ever, the same acini subsequently responded to treatment
with carbachol (1 mM) with a robust increase in intracellu-
lar calcium. Furthermore, acini infected with adenovirus
bearing either the human CCK2 or rat CCK1 receptor
gained the ability to respond strongly to CCK-8 (100 nM)
(fig. 2) or gastrin (data not shown).
Human pancreatic acinar cells do not express high levels of
CCK receptors
To investigate CCK receptor gene expression in human pan-
creatic acinar cells, we utilized RT-PCR to determine the
Fig. 3. RT-PCR amplifies both CCK1 and CCK2 receptor mRNA
from total RNA prepared from whole pancreas and isolated acini.
RNA was prepared from pancreatic acini and from whole pancreas.
RT-PCR was performed using 70 ng DNase-purified RNA and the
results shown are representatives of 3 independent experiments.
That the bands amplified represented the expected genes was veri-
fied by sequencing (modified from Ji et al. 2001 with permission).
presence of mRNA for CCK1 and CCK2 receptors and,
for comparison, the m3 Ach receptor. Standard RT-PCR
indicated the presence of minor levels of message for the
CCK1 receptor and more abundant levels of CCK2 recep-
tor and m3 Ach receptor mRNA (fig. 3). To quantitatively
compare the expression levels of the receptors we utilized
quantitative real-time RT-PCR. Standard curves were de-
Fig. 4. Quantitative real-time RT-PCR indicates that CCK receptor
mRNAs are expressed at low levels in human acinar cells. Real-
time quantitative RT-PCR was conducted using SYBR green IA to
monitor the PCR products with an I-Cycler real RT-PCR detection
system. Quantitation of mRNA expression was conducted using
standard curves for human CCK1, CCK2, and m3 Ach receptors
and using 65 pg of total RNA per acinar cell (Swift et al. 1984) as
an estimate of the cell numbers (reproduced from Ji et al. 2001 with
permission).
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Fig. 5. In situ hybridization detects m3 Ach receptor and insulin mRNA but not CCK receptor mRNA in human pancreas. In situ hybridiza-
tion was performed on 10 mm frozen sections of human pancreas using digoxigenin labeled RNA probes for CCK1R (A,B) CCK2R (C,D)
m3 AchR (E,F) and insulin (G,H). Sense probes (A,C,E,G) were utilized as negative controls. After incubation with the labeled probes the
sections were incubated with an anti-digoxigenin antibody conjugated with alkaline phosphatase and detected by the formation of a dark
precipitate. No specific localization was observed for CCK1 or CCK2 receptor mRNAs, whereas, m3 AchR mRNA was observed throughout
the acinar portion of the pancreas and insulin mRNA was observed localized to islets (arrow). Pancreatic cancer cell line panc-1 transfected
with human CCK2 receptor (J) is a positive control for CCK2R probe (modified from Ji et al. 2001).
veloped using plasmids bearing cDNAs for the receptors
(data not shown). Data from the quantitative RT-PCR
allowed the estimation of the amount of message for the
specific receptors that was present in the starting RNA
samples prepared from isolated human acini (fig. 4). This
analysis indicated that CCK1 receptor mRNA was ex-
pressed at a very low level, less than one copy per acinar
cell. The level of mRNA for the CCK2 receptor was also
low at approximately 5 copies per cell. Both CCK receptors
genes were expressed at an extent that was far lower than
that of the m3 Ach receptor, which was calculated to be
approximately 50 copies per cell.
In situ hybridization localizes mRNA for m3 ach receptors
and insulin but not CCK receptors in human pancreas
Quantitative RT-PCR studies indicated the presence of small
amounts of mRNA for CCK1 and CCK2 receptors in the
pancreas. The relative levels of mRNAs for these receptors
were not enriched in purified acini, suggesting that they were
not highly expressed in pancreatic islets. However, it re-
mained a possibility that this minor level of mRNA was a re-
sult of relatively high levels of expression within a non-acinar
cell population that co-purified with acini in our isolation
procedure. In order to investigate this possibility we con-
ducted in situ hybridization experiments using probes for
CCK1, CCK2 and m3 Ach receptors, as well as insulin.
Using this approach, it was not possible to identify any speci-
fic cells expressing either CCK receptor subtype mRNA
within the pancreas (fig. 5 B,D). However, these probes were
able to localized CCK receptor RNA in cell lines exogenously
expressing the appropriate CCK receptor genes (fig. 5 J). In
contrast to the lack of signal for CCK receptors, in situ hy-
bridization of sections from the same specimens with a probe
for the m3 Ach receptor mRNA indicated abundant expres-
sion localized to acinar cells (fig. 5 F). Furthermore, in situ
hybridization studies with the insulin probe also showed
strong and appropriate localization within islets (fig. 5 H).
Discussion
The present results indicate that human pancreatic acinar
cells do not respond to physiologic concentrations of either
CCK or gastrin in terms of cellular signaling or biological
activities that would be expected from our knowledge of the
function of these receptors in acinar cells from other spe-
cies. Because one of the primary criteria for determining
whether or not a hormone has a direct physiologic role in
regulating a specific cell is that treatment of that cell with
concentrations of the hormone likely to occur normally
within the organism elicits a functional response, these re-
sults suggest that neither CCK nor gastrin should be con-
sidered direct physiologic regulators of human pancreatic
acinar cells.
A major concern in these types of studies is the func-
tional integrity of the isolated cells. In the present study,
the functionality of the isolated acini was indicated by their
responsiveness to activation of m3 Ach receptors with car-
bachol and after gene transfer of CCK receptors. Because
the isolated human acini were capable of responding to
CCK in the presence of sufficient levels of receptor expres-
sion, these data support the hypothesis that lack of suf-
ficient receptor expression explains the lack of response to
CCK treatment.
The lack of responsiveness of the human acini to CCK
or gastrin in terms of changes in intracellular Ca2π was
particularly striking. Agonist occupancy of CCK1, CCK2,
or m3 Ach receptors leads to the activation of phos-
pholipase C and the production of inositol 1,4,5-tris-
phosphate (IP3) which then activates IP3 receptors and
causes the release of intracellular Ca2π. This signaling
pathway is exquisitely sensitive. Thus, the lack of respon-
siveness of the human acinar cells to CCK or gastrin in this
assay suggests that these receptors are absent from these
cells. Furthermore, these data strongly suggest that neither
CCK nor gastrin act as direct physiologic regulators of hu-
man pancreatic acinar cells. This is clearly different from
what is observed in rodents.
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To our knowledge only a single previous study had been
published indicating the effects of CCK analogues on bio-
logical actions in human acini (Susini et al. 1986). This pre-
vious study also found that human pancreatic acini did not
respond to physiologic concentrations of CCK. However, it
was reported that secretion could be stimulated by supra-
physiologic concentrations of cholecystokinin analogues. In
the current study we did not observe responses even at con-
centrations of 100 nM CCK, which is approximately 10,000
times the peak serum level of CCK (Liddle et al. 1985). The
explanation for this difference between the two studies is
unclear. However, it is unlikely that responses to extremely
high, non-physiologic, concentrations of CCK analogues
are biologically relevant.
Although functional responses to CCK or gastrin were
not observed in human pancreatic acini, CCK receptor gene
expression was detectable by RT-PCR as has been pre-
viously reported (Monstein et al. 1985). However, the level
of receptor mRNA expression in human pancreas has not
been previously quantitated, nor has receptor mRNA ex-
pression in isolated acini previously been investigated. We
utilized quantitative PCR (Higuchi et al. 1993) to measure
the levels of mRNA expression. Our data indicate that both
CCK1 and CCK2 receptor mRNA levels are very low in
the human pancreas. CCK1 levels were difficult to detect by
standard RT-PCR and were estimated to be less than one
copy per acinar cell by real-time quantitative RT-PCR.
CCK2 receptor mRNA levels, although higher than CCK1
receptor mRNA levels, were also very low. Compared to
the levels of mRNA for m3 Ach receptors, CCK2 receptor
message levels were at least 10 times lower. While there is
no direct correlation between mRNA levels and protein
levels, these data suggest that CCK receptor numbers are
likely much lower than m3 Ach receptor numbers. In con-
trast, in rat pancreatic acinar cells the copy numbers of
CCK1 receptor mRNA were estimated to be similar to
those observed for the m3 Ach receptor in man (data not
shown). Therefore, the likely explanation for the lack of
functional responses to CCK and gastrin is that the levels of
expression of receptors for these hormones are inadequate.
More direct evidence on this issue came from in situ hybridi-
zation experiments that did not observe CCK2 or CCK1
receptor mRNA localization on human pancreatic acinar
cells.
The current data support the hypothesis previously de-
rived from several independent lines of investigation that
the regulation of pancreatic secretion in man relies on in-
direct actions of CCK (Owyang 1996). In man, administra-
tion of CCK at concentrations that would not be expected
to activate CCK2 receptors elicits a strong secretion re-
sponse from the pancreas while administration of gastrin
causes a very limited response (Valenzuela et al. 1976; Can-
tor et al. 1986). Furthermore, CCK1, but not CCK2 anta-
gonists inhibit the stimulatory effects of a meal on pancre-
atic secretion (Cantor et al. 1991 & 1992). Therefore, CCK1
receptors appear to mediate the physiological effects of
CCK on human pancreatic secretion. However, utilizing
real-time quantitative PCR we found that CCK1 receptor
gene expression was extremely low in the pancreas. This low
level of expression helps explain the contradictions in the
literature concerning the ability to measure CCK1 receptor
mRNA in human pancreas. Autoradiographic binding
studies have also supported the absence of significant levels
of CCK1 receptors in the human pancreas (Tang et al.
1996). Finally, in the current study we observed no effects of
CCK on signaling or function in isolated human pancreatic
acini. Therefore, the evidence is very strong that the effects
of CCK on pancreatic secretion are not mediated directly
on acinar cells in man. Previously it has been shown that
man express CCK1 receptors on afferent neurons (Moriarty
et al. 1997) and anti-cholinergic drugs block the effects of
CCK on human pancreatic secretion (Soudah et al. 1992).
Thus, human pancreatic secretion is likely regulated exclus-
ively via the indirect effects of CCK on afferent neurones.
In summary, the data presented in this study indicate that
neither CCK nor gastrin directly activate cellular responses
on pancreatic acinar cells in man. Based upon the results of
real-time quantitative RT-PCR and in situ hybridization it
seems likely that the explanation for this lack of responsive-
ness is that these receptors are expressed only at very low
levels.
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